These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1148867)

  • 1. Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors.
    Prada MD; Saner A; Burkark WP; Bartholini G; Pletscher A
    Brain Res; 1975 Aug; 94(1):67-73. PubMed ID: 1148867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of LSD and BOL on the catecholamine synthesis and turnover in various brain regions.
    Persson SA
    Psychopharmacology (Berl); 1978 Oct; 59(2):113-6. PubMed ID: 31650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LSD as an agonist of dopamine receptors in the striatum.
    Pieri L; Pieri M; Haefely W
    Nature; 1974 Dec; 252(5484):586-8. PubMed ID: 4431521
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: regional differences.
    Ahn HS; Makman MH
    Brain Res; 1979 Feb; 162(1):77-88. PubMed ID: 104775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase--interaction of d-LSD with dopaminergic receptors.
    Bockaert J; Premont J; Glowinski J; Thierry AM; Tassin JP
    Brain Res; 1976 May; 107(2):301-15. PubMed ID: 1268730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LSD as an agonist and antagonist at central dopamine receptors.
    Von Hungen K; Roberts S; Hill DF
    Nature; 1974 Dec; 252(5484):588-9. PubMed ID: 4431522
    [No Abstract]   [Full Text] [Related]  

  • 9. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT
    De Gregorio D; Posa L; Ochoa-Sanchez R; McLaughlin R; Maione S; Comai S; Gobbi G
    Pharmacol Res; 2016 Nov; 113(Pt A):81-91. PubMed ID: 27544651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the behavioral effects of LSD by pretreatment with para-chlorophenylalanine and alpha-methyl-para-tyrosine.
    Appel JB; Lovell RA; Freedman DX
    Psychopharmacologia; 1970; 18(4):387-406. PubMed ID: 5491475
    [No Abstract]   [Full Text] [Related]  

  • 11. LSD as an agonist at mesolimbic dopamine receptors.
    Kelly PH; Iversen LL
    Psychopharmacologia; 1975 Dec; 45(2):221-4. PubMed ID: 2943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate.
    Whitaker PM; Seeman P
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5783-7. PubMed ID: 32537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repartition and drug sensitivity of dopamine and L-isoproterenol-sensitive adenylate cyclases in rat brain homogenates.
    Prémont J; Tassin JP; Thierry AM; Bockaert J
    Adv Biochem Psychopharmacol; 1976; 15():347-56. PubMed ID: 192054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin-sensitive adenylate cyclase in neural tissue and its similarity to the serotonin receptor: a possible site of action of lysergic acid diethylamide.
    Nathanson JA; Greengard P
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):797-801. PubMed ID: 4595572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysergic acid diethylamide: evidence for stimulation of pituitary dopamine receptors.
    Meltzer HY; Fessler RG; Simonovic M; Doherty J; Fang VS
    Psychopharmacology (Berl); 1977 Aug; 54(1):39-44. PubMed ID: 143671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is dopamine-sensitive adenylate cyclase involved in regulating the activity of striatal cholinergic neurons?
    Euvrard C; Premont J; Oberlander C; Boissier JR; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(3):241-5. PubMed ID: 530305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of quipazine and LSD on monoamines in the rat striatum.
    Miśkiewicz M; Rokosz-Pelc A; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca2+ channel blockade prevents lysergic acid diethylamide-induced changes in dopamine and serotonin metabolism.
    Antkiewicz-Michaluk L; Románska I; Vetulani J
    Eur J Pharmacol; 1997 Jul; 332(1):9-14. PubMed ID: 9298920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LSD and dopamine-sensitive adenylate-cyclase in various rat brain areas.
    Spano PF; Kumakura K; Tonon GC; Govoni S; Trabucchi M
    Brain Res; 1975 Jul; 93(1):164-7. PubMed ID: 166729
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
    Peters DA; Tang S
    J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.